Multifunctional compound stent as well as preparation method and application thereof
A complex and multifunctional technology, applied in the field of biomedical materials, can solve the problems of single function, difficulty in completely removing residual tumor cells, and low efficiency in treating tumors, and achieve enhanced effects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0089] The embodiment of the present application provides the preparation method of BGC powder, BGC scaffold and BGC scaffold mixed with heme (HM) and doxorubicin (DOX), specifically including:
[0090] 1. Preparation of BGC powder (bioactive glass-ceramic powder): BGC powder was prepared by a sol-gel method. The process is described as follows: 156.81 mLTEOS (tetraethyl tetrasilicate) was added to 200 mL deionized water, followed by 25.00 mL HNO 3 Solution (2moL / L) was added to the above solution and stirred for 30min. Next, 59.04g Ca(NO 3 ) 2 4H 2 O and 8.53mLTEP (triethyl phosphate) were added to the above solution and stirred for 6h. Then, the solution was placed in an air oven at 65°C for 24h, and then the product was dried in an air oven at 120°C for 48h. The dried product was transferred to a planetary high-energy ball mill and ground at a speed of 600 rpm for 4 h. Then the product was calcined in a high-temperature sintering furnace with a maximum temperature of ...
Embodiment 2
[0094] The embodiment of the present application provides a preparation method of BGC-HM scaffolds mixed with different proportions of heme HM, including:
[0095] 1. Add the heme powder into deionized water, and grind it at a speed of 500 rpm for 4 hours by a planetary high-energy ball mill. After grinding, the heme powder is dried and collected. Add 0.1 g of polylactic acid to 5 mL of dichloromethane, and stir to completely dissolve it. Then, three different weights of heme powder (0.02g, 0.06g and 0.12g) were put into the above polylactic acid solution in dichloromethane, respectively. After stirring for 10 minutes and ultrasonically dispersing for 30 minutes, mixed solutions of heme and polylactic acid were obtained, which were marked as 1HM mixed solution, 2HM mixed solution and 3HM mixed solution.
[0096] 2. Immerse the BGC stent prepared in Example 1 into 1HM mixed solution, 2HM mixed solution and 3HM mixed solution respectively. After the BGC scaffolds were complet...
Embodiment 3
[0102] The embodiment of the present application provides a method for preparing BGC-HM scaffolds mixed with different ratios of doxorubicin, including:
[0103] 1. Weigh 2mg, 5mg, 10mg and 15mg of doxorubicin, add doxorubicin to 5mL of polylactic acid in dichloromethane solution respectively, the concentration of polylactic acid in the polylactic acid in dichloromethane solution is 0.02g / mL . After stirring and ultrasonic dispersion, the BGC scaffold was immersed in the above mixed solution for 4 s, and then taken out.
[0104] 2. The stents were respectively immersed in polylactic acid dichloromethane solutions containing 2mg, 5mg, 10mg and 15mg of doxorubicin, and the taken out stents were named as BGC-1DOX, BGC-2DOX, BGC-3DOX and BGC-4DOX stents.
[0105] 3. Detect the appearance, SEM, red fluorescence and doxorubicin release of the above-mentioned BGC-1DOX, BGC-2DOX, BGC-3DOX and BGC-4DOX scaffolds, the results are as follows image 3 shown. image 3 A is the appearanc...
PUM
Property | Measurement | Unit |
---|---|---|
concentration | aaaaa | aaaaa |
concentration | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com